ArticleWorld journal of clinical cases2022

Dual biologic therapy with ocrelizumab for multiple sclerosis and vedolizumab for Crohn's disease: A case report and review of literature.

Michael Au et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.